BGHL (GBP): NAV(s)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
28
BGHL (GBP): NAV(s)

                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

Close of business 28 Jan 2019.

Estimated NAV

  Euro Shares Sterling Shares
Estimated NAV €  21.9945 £  19.6566
Estimated MTD return  -0.05 %  0.06 %
Estimated YTD return  -0.05 %  0.06 %
Estimated ITD return  119.95 %  96.57 %

NAV and returns are calculated net of management and performance fees

Market information

Euro Shares Amsterdam (AEX) London (LSE)
Market Close €  17.00 N/A
Premium/discount to estimated NAV  -22.71 % N/A
     
Sterling Shares Amsterdam (AEX) London (LSE)
Market Close N/A GBX 1,500.00
Premium/discount to estimated NAV N/A  -23.69 %

Transactions in own securities purchased into treasury

Ordinary Shares Euro Shares Sterling Shares
Number of shares N/A N/A
Average Price N/A N/A
Range of Price N/A N/A

           

                                           

Liquidity Enhancement Agreement Euro Shares Sterling Shares
Number of shares N/A N/A
Average Price N/A N/A

BGHL Capital

BGHL Ordinary Shares Euro Shares Sterling Shares
Shares Outstanding  28,782,231  608,712
Held in treasury N/A N/A
Shares Issued  28,782,231  608,712

Estimated BG Fund NAV

Class B Euro Shares (estimated) €  179.3088

The Class B Euro Shares of BG Fund are not subject to investment manager fees, as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.

For further information please contact:

Boussard & Gavaudan Investment Management, LLP. Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.com

The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.

This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

Neither the Company nor BG Fund ICAV has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.

You should always bear in mind that:

  • all investment is subject to risk;
  • results in the past are no guarantee of future results;
  • the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and
  • if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice.

This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 9

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 301

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 359

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 536

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 15

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 268

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Kodiak Gas Services: Anticipating Strong Earnings Results

Updated Category News Views 169

Kodiak Gas Services: Anticipating Strong Earnings Results Kodiak Gas Services (NYSE: KGS) is on the verge of announcing its quarterly earnings. Investors are keen to gain insights into potential performance as the company prepares for its report. Analysts are projecting an earnings per share (EPS) of $0.51, heightening expectations for this upcoming announcement....

Continue Reading
Anna Shlimak Steps Up as CFO to Propel Cronos Forward

Updated Category News Views 186

Anna Shlimak Steps into CFO Role at Cronos Group Inc. Cronos Group Inc. (NASDAQ: CRON), a leading name in the cannabinoid sector, has recently announced a significant shift in its executive team with Anna Shlimak appointed as the new Chief Financial Officer. This transition marks a pivotal moment for Cronos, poised to leverage Anna’s extensive experience within the...

Continue Reading
Investigation into Major Firms: Legal Rights for Shareholders

Updated Category News Views 325

Understanding the Recent Investigations Johnson Fistel, PLLP, a notable shareholder rights law firm, has initiated inquiries into potential legal violations involving several major corporations: Elanco Animal Health Incorporated (NYSE: ELAN), Masimo Corporation (NASDAQ: MASI), Fidelity National Information Services, Inc. (NYSE: FIS), and Super Micro Computer, Inc....

Continue Reading
Copa Holdings Reports Impressive Passenger Traffic Growth

Updated Category News Views 96

Overview of Copa Holdings' Monthly Performance Recently, Copa Holdings, S.A. (NYSE: CPA) shared its preliminary passenger traffic statistics for a noteworthy month. Following a trend of growth, these statistics for November highlight significant increases and operational achievements for the airline. Passenger Traffic Insights For November, Copa Holdings reported an...

Continue Reading
Cardinal Health Readies for Q4 Earnings: Market Insights Ahead

Updated Category News Views 151

Cardinal Health Prepares for Its Fourth Quarter Earnings Report Cardinal Health, Inc. (NASDAQ: CAH) is poised to announce its fourth quarter earnings, which is expected to generate significant attention from investors and analysts alike. The upcoming earnings report will provide insights into the company's performance over the past quarter, and many are curious to know...

Continue Reading